Acen Corporation (ACPIF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acen Corporation

    PNK: ACPIF · Real-Time Price · USD
    0.07
    -0.00 (-2.78%)
    At close: Jan 24, 2025, 1:00 AM

    Acen Income Statement

    Financials in PHP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 36.65B 35.61B 35.05B 37.02B 36.37B 38.58B 39.67B 36.9B 35.16B 32.36B 28.55B 27.68B 26B 24B 23.82B 21.51B
    Cost of Revenue
    		 27.47B 26.76B 27.63B 30.82B 31.76B 35.94B 36.83B 34.43B 34.19B 30.3B 25.72B 24.91B 21.47B 17.88B 17.4B 14.36B
    Gross Profit
    		 9.17B 8.85B 7.42B 6.2B 4.61B 2.64B 2.84B 2.47B 974.57M 2.07B 2.84B 2.77B 4.53B 6.11B 6.42B 7.15B
    Operating Income
    		 3.96B 4.28B 7.42B 8.89B 9.04B 9.13B 7.39B 7.07B 5.72B 7.28B 8.34B 7.64B 8.17B 8.55B 7.3B 7.14B
    Interest Income
    		 7.9B 9.43B 10.54B 10.59B 10.5B 6.64B 6.6B 6.16B 5.66B 5.5B 4.85B 4.66B 3.59B 2.21B 1.53B 565.68M
    Pretax Income
    		 10.94B 14.17B 15.29B 13.32B 12.62B 16.73B 16.11B 15.85B 13.94B 6.5B 6.58B 6.06B 6.74B 6.32B 4.98B 4.68B
    Net Income
    		 9.36B 8.97B 9.46B 8.09B 7.4B 15.5B 15.1B 14.68B 13.06B 5.1B 4.74B 4.38B 4.81B 4.65B 4.04B 4.04B
    Selling & General & Admin
    		 3.27B 3.45B 3.39B 3.51B 2.51B 1.75B 1.52B 1.27B 955.89M 903.75M 888.1M 1.51B 1.47B 1.32B 1.63B 1.29B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 2.78B 1.97B 1.1B 115.43M 239.99M 483M 511.65M 712.26M 677.23M 655.51M 638.23M 1.67B 1.61B 1.68B 1.8B 735.63M
    Operating Expenses
    		 6.05B 5.4B 6.32B 6.06B 5.8B 6.05B 4.19B 3.47B 2.54B 1.99B 2.18B 2.65B 2.77B 2.53B 2.32B 1.99B
    Interest Expense
    		 3.12B 2.57B 2.07B 1.93B 1.77B 1.74B 1.85B 2.16B 2.08B 2.01B 1.95B 1.73B 1.67B 1.75B 1.75B 1.89B
    Selling & Marketing Expenses
    		 39.7M 42.73M 34.6M 32.97M 39.65M 30.1M 30.84M 30.24M 22.95M 21.14M 22.31M 21.29M 17.16M 8.47M 4.93M 4.93M
    Cost & Expenses
    		 33.52B 32.16B 33.95B 36.89B 37.57B 41.99B 41.02B 37.9B 36.73B 32.28B 27.89B 27.55B 24.24B 20.42B 19.72B 16.35B
    Income Tax Expense
    		 829.92M 584.23M 1.07B 496.84M 282.3M -229.8M -601.88M -437.19M -662.1M -146.7M 83M -429.22M 149.43M 168.78M 131.76M 533.56M
    Shares Outstanding (Basic)
    		 39.68B 39.68B 45.86B 39.68B 39.68B 39.68B 39.68B 39.68B 39.68B 39.26B 39.05B 38.46B 38.32B 26.42B 20.26B 15.81B
    Shares Outstanding (Diluted)
    		 39.68B 39.68B 39.68B 39.68B 39.68B 39.68B 39.68B 39.68B 39.68B 39.26B 39.05B 38.46B 38.38B 26.42B 20.43B 15.81B
    EPS (Basic)
    		 0.20 0.19 0.22 0.21 0.19 0.40 0.39 0.38 0.34 0.13 0.14 0.16 0.23 0.25 0.26 0.44
    EPS (Diluted)
    		 0.21 0.20 0.23 0.21 0.19 0.40 0.39 0.38 0.34 0.13 0.14 0.16 0.23 0.25 0.26 0.44
    EBITDA
    		 14.1B 11.11B 11.52B 7.21B 6.12B 6.33B 4.77B 7.06B 7.9B 9.5B 10.5B 9.77B 10.18B 10.48B 9.2B 9.06B
    EBIT
    		 13.92B 13.38B 13.99B 11.98B 11.18B 18.48B 17.98B 18B 16.04B 8.54B 8.53B 7.77B 9.4B 9.05B 8.15B 9.45B
    Depreciation & Amortization
    		 2.59B 2.09B 1.77B 1.59B 1.57B 1.68B 1.87B 2.04B 2.18B 2.22B 2.15B 2.12B 2.01B 1.93B 1.9B 1.92B

    Add to Watchlist